Cellectis

02.11.2023 • News

AstraZeneca Invests $245 Million in French Biotech Cellectis

Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the development of therapeutics across oncology, immunology and rare diseases.

31.01.2014 • News

Bayer CropScience and Cellectis extend R&D Pact

Top-Feature

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Free Virtual Event

Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.